By Brendan Bures.
Two main speaking factors amongst Democratic presidential candidates forward of the 2020 Election has been common well being care and marijuana reform. However these two points may have extra in widespread than you assume. Based on one cannabis CEO, opening medicare for all may “dramatically” enhance medical marijuana entry.
“I believe it will eradicate the monetary subsidy for folks to make use of merchandise like opioids,” Columbia Care CEO Nicholas Vita informed Yahoo Finance. A system that doesn’t overly depend on opioids may “truly open the door for [patients] to make use of merchandise which might be doubtlessly a lot much less dangerous and extra efficacious like medical cannabis.”
The opioid epidemic locations a severe financial burden on the nation. Well being care and courtroom bills, in addition to wasted productiveness, brought on by the opioid disaster value about $78.5 billion yearly, based on The Facilities for Illness Management and Prevention. A report from the Nationwide Institutes of Well being estimates that just about 130 folks die each day from an opioid overdose.
Medicare is as soon as once more a scorching button political situation, partly as a result of Sen. Bernie Sanders launched his Medicare For All Act. Whereas Medicare often solely covers these ages 65 or older, Sanders’ plan would offer well being look after all People. If that occurs, corporations like Vita’s must be ready for the way medical marijuana will match into the system.
“Due to the best way cannabis is dealt with, there’s no entry to credit score, which is the most typical type of transactions for shoppers. We thought that assuaging some of the vital bottlenecks, we will truly improve entry in a big manner.”
Photograph by David McNew/Workers/Getty Photos
This text was initially posted on The Contemporary Toast.
This is What CBD Cannot Do For You
The previous article is from certainly one of our exterior contributors. It doesn’t symbolize the opinion of Benzinga and has not been edited.
© 2019 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.